To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
Clinical trial NCT06901505 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06901505
- Sponsor
- Akebia Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-24
- Primary completion
- 2026-08-01
- Enrollment
- 353
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.